withdrawal. An inducible NANOG overexpression line (iNANOG) was established based on the 77 iVPR system. We found a significant increase in NANOG protein after Dox induction. INANOG 78 cells upregulated naïve pluripotency genes and were able to grow for a significant length of time in 79 a naïve state medium containing ERK and GSK3 inhibitors and human LIF. The iVPR system can 80 be a valuable system to control gene expression from endogenous loci and serve as platform for 81 genome wide screens to identify new genes that can regulate stem cell self-renewal and 82 differentiation. 83 84 Results 85
DCas9-VPR mediated robust ectopic and endogenous gene activation in human cell lines 86
To construct a robust and tunable gene activation system in hPSCs, we first compared the (Fig. 1A) . We constructed 89 plasmids to express gRNA targeting the TetO sequence (gTetO), and tested the ability of 90 dCas9-VPR+gTetO or dCas9-VP64+gTetO to activate the synthetic TRE promoter driving 91 enhanced blue fluorescent protein expression (TRE-BFP) in 293FT cells (Fig. 1A) . The Tet 92 transactivator (rtTA) was used as positive control (Fig. 1B) . DCas9-VPR strongly activated BFP 93 fluorescence, 43.1% of cells were BFP positive, while in the rtTA+Dox and dCas9-VP64 groups, 94 only 28.2% and 5.8% of cells activated BFP, respectively ( Fig. 1C and D) . Moreover, dCas9-VPR 95 resulted in the strongest mean BFP fluorescence intensity, indicating that it is the strongest 96 activator among the three (Fig. 1D ). 97
We next tested the dCas9-VPR function in hESCs. DCas9-VPR, gTetO, and TRE-BFP 98 plasmids were co-transfected into H9 hESCs. In another group, rtTA and TRE-BFP plasmids were 99 co-transfected. FACS analysis showed that nearly 17% of cells in the dCas9-VPR group turned on 100 BFP, while 24.7% of cells in the rtTA group were BFP positive after Dox induction, and only 0.6% 101 of cells exhibited BFP fluorescence without Dox (Fig. 1E) . Interestingly, the dCas9-VPR group 102 showed the strongest mean fluorescence intensity (Fig. 1F ). This is consistent with our result based 103 on 293FT cells and proves that dCas9-VPR is a robust transcription activator, even compared with 104 rtTA. We also tested the activation effect of dCas9-VPR in mouse embryonic stem cells (mESCs) 105 and mouse embryonic fibroblasts (MEFs) and obtained similar results ( Fig. S1A and B) . 106 genome integrity of hPSCs, we engineered an iVPR system by inserting the CAG promoter driving 142 the rtTA expression cassette and the TRE promoter driving the dCas9-VPR cassette into the two 143 alleles of the AAVS1 locus on chromosome 19. H9 hESCs were co-transfected with two donor 144 plasmids containing dCas9-VPR and M2rtTA, as well as a pair of Cas9 nickase plasmids with 145 AAVS1 targeting gRNAs to induce DNA double-strand break (DSB) and homology recombination 146 (HR) (Fig. S2A) . After puromycin and neomycin double selection for 2 weeks, we picked and 147 expanded 17 clones. Upon addition of Dox, all the clones showed clear induction of dCas9-VPR 148 protein expression ( Fig. S2B ). Genomic DNA PCR was performed to select correct targeted clones 149 and rule out random insertions ( Fig. S2C ). Clone 2, 6 and 8 had targeted insertion at both AAVS1 150 alleles and without any random insertion ( Fig. S2C ). They were chosen for further analysis. 151
Southern blot confirmed that in all three clones, both alleles of AAVS1 contained the correct 152 insertion ( Fig. 4A and B ). Q-PCR analysis showed that in hESCs, without Dox treatment, little 153 dCas9-VPR transcript could be detected, while after Dox addition, strong dCas9-VPR expression 154 was induced ( Fig. 4C ). Karyotype analysis showed that all three clones had normal 46XX karyotype 155 ( Fig. S2D ). IVPR clone 2 was chosen for further study. Without Dox, we could not detect any 156 dCas9-VPR protein in iVPR cells. The dCas9-VPR protein appeared after 12 hours of Dox addition 157 and reached a plateau at 24 hours ( Fig. 4D ). While 6 hours after Dox withdrawal, the dCas9-VPR 158 protein decreased, by 12 hours, it decreased to a low level and could not be detected anymore after 159 24 hours (Fig. 4D ). The induction of dCas9-VPR from the AAVS1 locus was not affected by 160 differentiation. We induced mesoderm differentiation by culturing cells in an RPMI medium 161 supplemented with albumin, ascorbic acid, transferrin, selenite, BMP4 (5ng/ml) and CHIR99021 (2 162 μM) as described by Burridge et al. (Burridge et al. 2015) . Q-PCR analysis showed that after 3 days 163 of differentiation, pluripotency marker genes OCT4 and SOX2 were significantly downregulated, 164 while dCas9-VPR was highly expressed as long as Dox was present, regardless whether cells were 165 in hESC culture medium E8 or in the differentiation medium ( Fig. 4E ). Genes related to mesoderm 166 differentiation and epithelial to mesenchymal transition, such as SNAIL, were strongly upregulated 167 by BMP4 and CHIR99021, confirming that hESCs had taken a mesoderm fate ( Fig. 4E ). These 168 results suggest that the iVPR hESC line can be used for efficient and reversible gene activation. 169 170 Upregulation of NANOG by dCas9-VPR promoted naïve state of pluripotency 7
The iVPR system provided a unique platform to investigate gene functions through activation 172 from the endogenous locus. NANOG is a key regulator of pluripotency. We generated iNANOG 173 hESCs by transfecting the PiggyBac based gNANOG plasmid described earlier into iVPR clone 2, 6,
We also tested the time window of NANOG down-regulation after Dox withdrawal. NANOG mRNA 179 was unchanged during the first 12 hours and decreased after 24 hours. It approached the background 180 level after 48 hours ( Fig. 5B ). We next examined the change in NANOG protein level after Dox 181 addition and withdrawal. Western blot revealed that dCas9-VPR protein became detectable 12 hours 182 after Dox induction and reached a significant level after 24 hours ( Fig. 5C , dCas9, long exposure; 183 LE). Accordingly, NANOG protein showed an obvious increase after 24 hours and maintained at 184 high level as long as dCas9-VPR was present ( Fig. 5C , NANOG, LE). On the other hand, 6 hours 185 after Dox removal, the dCas9-VPR protein decreased significantly ( Fig. 5D , dCas9, short exposure; 186 SE). The decline of the dCas9-VPR protein was most apparent during the first 24 hours. After 4 days 187 without Dox, dCas9-VPR protein became almost undetectable ( Fig. 5D ). Similarly, the NANOG 188 protein level dropped to the background level after 4 days of Dox withdrawal ( Fig. 5D ). Q-PCR 189 analysis showed that after Dox induction, iNANOG significantly upregulated naïve state related 190 genes such as OCT4, PRDM14, GDF3, and LEFTYB, while the early differentiation genes such as 191 AFP was significantly downregulated (Fig. 5E ). XIST, a long non-coding RNA involved in X 192 chromosome inactivation were also downregulated after NANOG induction (Fig. 5F ). The 193 expression of SSEA3, a more rigorous pluripotency cell surface marker, was increased and became 194 more homogeneous after NANOG elevation ( Fig. 5G and Fig. S3 ). In addition to elevated expression 195 of pluripotency genes, iNANOG cells also showed enhanced survival and proliferation abilities. 196
Clonogenicity assay showed that after Dox induction, twice as many clones formed from dissociated 197 iNANOG single cells ( Fig. 5H and I ). Finally, we tested whether NANOG upregulation by iVPR 198 may facilitate hESCs to enter the naïve state of pluripotency. IVPR cells and iNANOG cells were . We refer to this medium as 2iL/FK. iNANOG cells showed further enhanced 218 proliferation in the 2iL/FK medium and were able to form large, dome-shaped colonies ( Fig. 6B) , 219 while cells without NANOG overexpression could only form small colonies ( Fig. S4A ). E3.5 220 blastocysts were collected from ICR mice for hESC injection. iNANOG cells and WTSG cells 221 cultured with or without Dox, in either the E8 or 2iL/FK medium, were dissociated into single 222 cells. 10-15 single cells were injected into the blastocoel cavity and cultured in a 1:1 mixed 223 KSOM:2iL/FK medium for 24 hours (Fig. 6A ). Because cells without NANOG overexpression 224 only formed small colonies on feeder in the 2iL/FK medium, we could not obtain sufficient pure 225 hESCs for blastocyst injection. Therefore, this group was omitted from this series of experiments. 226
Since all cells used for injection contained GFP transgene expressed from the gNANOG plasmid, 227 the location of human cells in the mouse blasocysts could be followed directly under the 228 fluorescence microscope. 4-6 hours after injection, most blastocysts contained GFP positive 229 human cells ( Fig. 6B and C). After 24 hours of culture, many embryos still contained hESCs ( Fig.  230   6B ). We used time-lapse imaging to monitor the activity of hESCs in mouse blastocysts over time 231
(Supplementary movie S1). Interestingly, endogenous NANOG overexpression strongly enhanced 232 the survival of hESCs in mouse blastocysts. 12 hours after injection, 2iL/FK cultured Dox induced 233 gNANOG cells could be found in approximately 82% of blastocysts, while E8 cultured Dox 234 induced gNANOG cells were alive in 73% of blastocysts ( Fig. 6C and S4B ). In contrast, without 235 Dox induction, E8 cultured iNANOG cells could only be seen in 49% of injected blastocysts (Fig. 236 6C and S4B). We next analyzed the locations of the transplanted hESCs. Injected embryos were 237 fixed after 24 hours of culture, stained with CDX2 (a trophectoderm marker) and β-Catenin, and 9 observed with a confocal microscope. Different integration patterns were shown: hPSCs integrated 239 into the ICM region (ICM), in both the ICM and the trophectoderm (Multiple), only in the 240 trophectoderm (TE), and disappeared (None) ( Fig. 6D ). We also performed live imaging to 241 monitor the behavior of iNANOG cells in the mouse blastocyst. Interetingly, 2iL/FK cultured 242 iNANOG cells tend to migrate with mouse inner cell mass cells as blastocyst hatching from the 243 zona pellucida (Fig. 6E ). NANOG overexpression significantly improved the percentage of cells 244 remaining in blastocysts, and the 2iL/FK culture further increased the ICM integration proportion 245 ( Fig. 6F , G, and S4C). On average, two 2iL/FK or E8 cultured iNANOG cells could be found in 246 the ICM region 24 hours after injection, while without NANOG overexpression, hardly any GFP 247 cells were seen in the ICM ( into the locus (Ordovás et al. 2015) . We tested the iVPR expression in both undifferentiated hESCs 293 and after induction of mesoderm differentiation. The level of dCas9-VPR transcripts was even 294 higher upon Dox treatment after mesoderm induction (Fig. 4E) . The iVPR and iNANOG cells 295 have been maintained for more than 6 months, and we did not observe any reduction in the level of 296 dCas9-VPR or NANOG induced by Dox. Thus, results us and other groups suggested that, in most 297 cases, AAVS1 locus integration is a reliable approach to generate transgenic hPSCs. 2014), because Dox treated iNANOG cells showed significantly higher clonogenicity over Dox 318 treated iVPR cells ( Fig. 5H and I) . The enhanced survival ability seemed to have a significant 319 influence on whether hPSCs can integrate with the ICM of mouse blastocysts during in vitro 320 culture. We found that even when iNANOG cells were in the primed state, after injection into 321 mouse blastocysts, more cells remained inside the blastocysts and some of the cells were able to 322 integrate with mouse ICM cells ( Fig. 6F and G in 37 °C, 5% CO 2 incubator. After injected embryos reformed blastocoel, the chimera embryos 424 were live cell imaged using Leica microscope fitted with a live cell imaging system and fixed after 425 24-36 hours post-injection for staining and confocal imaging. For embryo immunostaining, zona 426 pellucida-free injected embryos were fixed with 3.5% paraformaldehyde, permeabilized in 0.5% 427 Triton X-100 (Sigma) and blocked with 5% BSA and then incubated with primary antibodies against 428 CDX2 (BioGenex), 
